Christine Utter

2017

In 2017, Christine Utter earned a total compensation of $870.7K as Principal Financial Officer and Treasurer at PTC Therapeutics.

Compensation breakdown

Bonus$25,000
Non-Equity Incentive Plan$142,067
Option Awards$315,657
Salary$317,596
Stock Awards$43,797
Other$26,624
Total$870,741

Utter received $317.6K in salary, accounting for 36% of the total pay in 2017.

Utter also received $25K in bonus, $142.1K in non-equity incentive plan, $315.7K in option awards, $43.8K in stock awards and $26.6K in other compensation.

Rankings

In 2017, Christine Utter's compensation ranked 9,640th out of 14,666 executives tracked by ExecPay. In other words, Utter earned more than 34.3% of executives.

ClassificationRankingPercentile
All
9,640
out of 14,666
34th
Division
Manufacturing
3,717
out of 5,772
36th
Major group
Chemicals And Allied Products
1,288
out of 2,075
38th
Industry group
Drugs
1,037
out of 1,731
40th
Industry
Pharmaceutical Preparations
817
out of 1,333
39th
Source: SEC filing on April 30, 2018.

Utter's colleagues

We found six more compensation records of executives who worked with Christine Utter at PTC Therapeutics in 2017.

2017

Stuart Peltz

PTC Therapeutics

Chief Executive Officer

2017

Marcio Souza

PTC Therapeutics

Chief Operating Officer

2017

Mark Boulding

PTC Therapeutics

Chief Legal Officer

2017

Mark Rothera

PTC Therapeutics

Former Chief Commercial Officer

2017

Neil Almstead

PTC Therapeutics

Executive Vice President, Research, Pharmaceutical Operations & Technology

2017

Shane Kovacs

PTC Therapeutics

Chief Financial Officer

News

You may also like